C.R. Bard, Inc - Buy the Bard! at FinGad.com

Vote

Categorie: Equities
Submitted 11 months ago by

Fred

C.R. Bard, Inc (NYSE:BCR) Buy the Bard!! Research reports say 12,000 companies engage in the manufacture of medical supplies and devices with combined annual revenue of about $50 billion. The industry has become more concentrated, with the 50 largest companies holding close to 60 percent of the market. In some market segments, concentration is very high. Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and research & development. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. Annual revenue per employee is about $200,000. Major product segments are general medical supplies; surgical instruments; therapeutic devices such as stents, artificial joints, and pacemakers; and diagnostic equipment. Low-cost manufacturing efficiency is the main concern of companies that make low-technology products like latex gloves, tape, gauze sponges, and syringes. Technological innovation is the main feature of companies that produce diagnostic and therapeutic devices and instruments, derived from the explosive development of medical knowledge and treatment during the last decade. The industry reflects the highly specialized medical treatments recently made available.... More...

[ 0 Comments | Send To A Friend | Bookmark Review ]

0 comments ↓

Please Login or Register to comment